Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.\new Filed Acc 0001144204-08-051100

10% owner bought 25,000 shares at $4.03 ($100,655)

From the SEC's structured data for this filing

Trades in this filing

Trinad Capital Master Fund Ltd. · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2008-08-29 Purchase : show line 1 in the form +25,000 $4.03 $100,655 2,313,170 D
Open-market purchases · 25,000 sh · avg $4.03 · $100,655
Loading xslF345X03/v125555_ex.xml…